Patrick Hwu

14PUBLICATIONS
232CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 21, 2026
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Feb 27, 2026
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis.

Islam Eljilany, Eissa Jafari, Abdullah Alhumaid

|Jun 23, 2025
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development.

Leisha A Emens, Christine Moussion, Patrick Hwu

|May 23, 2025
Facts and Hopes: Toward the Next Quantum Leap in Melanoma.

Keith T Flaherty, Andrew E Aplin, Michael A Davies

|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Ahmad A Tarhini, Alyssa Obermayer, Sandra J Lee

Pageof 3

Frequent Collaborators

4 joint publications

Chantale Bernatchez

3 joint publications

Khalida Wani

3 joint publications

Michael A Davies

3 joint publications

Jennifer A Wargo